As mentioned above, tumor with high B2M expression had increased MHC-I-based antigen presentation and associated CD8 cytolytic responses, which gliomas were likely to adopt immune evasive mechanisms through expression of immune checkpoint molecules. The gene discussed is B2M; the disease is central nervous system cancer.